Modulation of MDR1 and MRP3 Gene Expression in Lung Cancer Cells after Paclitaxel and Carboplatin Exposure

Carboplatin-paclitaxel is a reference regimen in the treatment of locally advanced or disseminated non-small cell lung cancer (NSCLC). This paper discusses the multidrug resistance developed with this drug combination, which is one of the major obstacles to successful treatment. In order to understa...

Descripción completa

Detalles Bibliográficos
Autores principales: Melguizo, Consolación, Prados, Jose, Luque, Raquel, Ortiz, Raúl, Caba, Octavio, Álvarez, Pablo J., Gonzalez, Beatriz, Aranega, Antonia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Molecular Diversity Preservation International (MDPI) 2012
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3546711/
https://www.ncbi.nlm.nih.gov/pubmed/23443122
http://dx.doi.org/10.3390/ijms131216624

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3546711/
https://www.ncbi.nlm.nih.gov/pubmed/23443122
http://dx.doi.org/10.3390/ijms131216624

Ejemplares similares